Total trials
33
Active
2
Phase 3
0
Total enrollment
61,534
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Cystic Fibrosis3
- Type 2 Diabetes3
- Cystic Fibrosis-related Diabetes2
- Aging2
- Dental Erosion2
- Diabetes Mellitus, Type 22
- End Stage Renal Disease2
- Type2 Diabetes2
Frequently asked questions about University of Portsmouth
- How many clinical trials does University of Portsmouth have on ClinicalTrials.gov?
- University of Portsmouth is listed as the lead sponsor on 33 clinical trials in ClinicalTrials.gov, 2 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Portsmouth's trials are in Phase 3?
- 0 of University of Portsmouth's trials are in Phase 3.
- What therapeutic areas does University of Portsmouth focus on?
- University of Portsmouth's most-studied conditions on ClinicalTrials.gov are Cystic Fibrosis, Type 2 Diabetes, Cystic Fibrosis-related Diabetes, Aging, Dental Erosion.